Exactly, its part of a bigger picture. The trials have been going on for quite some time this is a well laid out plan by the company. The next phase of trials and approval they are shooting for now, is a much much larger market.
From wiki as well you can search the net it is well documented, we are talking a very large market that they are attacking, burn treatment although a a cash cow 6-12 months from now, their future which they are looking at for the year after etc. is much larger.
"In addition to the US studies for ReCell in burns and scars, ReCell is being studied in a number of small scale post-marketing studies in Europe for venous leg ulcers, Vitiligo, acne scars, scar remodeling, facial rejuvenation (wrinkle revision), treatment of donor graft sites, and hard to heal burn wounds in the elderly."
Its going to be a lovely year and year after that, and ride into the future. The outlook as a real investment is rather bight.
Peace out.
News 
Market Data 
Discover 
